Showing 1 - 3 results of 3 for search 'Denise F Johnson', query time: 0.03s Refine Results
  1. 1
    Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

    Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection. by Denise F Johnson, LaShaunda L Malone, Sarah Zalwango, Joy Mukisa Oketcho, Keith A Chervenak, Bonnie Thiel, Harriet Mayanja-Kizza, Catherine M Stein, W Henry Boom, Christina L Lancioni, Tuberculosis Research Unit

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

    Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. by C Scott Mahan, Maria Walusimbi, Denise F Johnson, Christina Lancioni, Edwin Charlebois, Joyce Baseke, Keith A Chervenak, Roy D Mugerwa, Diane V Havlir, Harriet Mayanja-Kizza, Christopher C Whalen, W Henry Boom, Uganda-Case Western Research Collaboration

    Published 2010-02-01
    Get full text
    Article
  3. 3
    Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.

    Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment. by Melissa R Nyendak, Byung Park, Megan D Null, Joy Baseke, Gwendolyn Swarbrick, Harriet Mayanja-Kizza, Mary Nsereko, Denise F Johnson, Phineas Gitta, Alphonse Okwera, Stefan Goldberg, Lorna Bozeman, John L Johnson, W Henry Boom, Deborah A Lewinsohn, David M Lewinsohn, Tuberculosis Research Unit and the Tuberculosis Trials Consortium

    Published 2013-01-01
    Get full text
    Article

Search Tools: